We at UCSF take your care seriously. Click here for COVID-19 information

University of California San Francisco

Our Team

Mia Salans

Mia Salans, MD, MAS



  • Radiation Oncology Residency, University of California, San Francisco (2022-2026)
  • Transitional Year Internship, Memorial Sloan Kettering Cancer Center (2021-2022)
  • Medical Degree, University of California, San Diego (2016-2021)
  • Master of Advanced Studies, Clinical Research, University of California, San Diego (2019-2020)
  • Bachelor of Arts, Integrative Biology, University of California, Berkeley (2010-2014)

Awards & Honors 

  • American Medical Women’s Association Glasgow‐Rubin Certificate of Commendation for Academic Achievement, University of California, San Diego (2021)
  • Best of ASTRO abstract (2020)
  • Altman Clinical and Translational Research Institute TL1 Training Grant, University of California, San Diego (2019‐2020)
  • National Institute on Aging Medical Student Training in Aging Research Grant, University of California, San Diego (2017)
  • Integrative Biology Honors Program, University of California, Berkeley (2013‐2014)
  • Winfred Kenyon Merit Scholarship, University of California, Berkeley (2014‐2014)
  • Estha M. Rodkey Merit Scholarship, University of California, Berkeley (2013‐2014)
  • Odell Wilson Merit Scholarship, University of California, Berkeley (2013‐2014)

Selected Publications and Abstracts

  • Hopper, A, Salans, M, Karunamuni, R, Hattangadi-Gluth, J. Neurocognitive considerations in the treatment of meningioma with radiation therapy: Applications for quantitative neuroimaging and precision radiation medicine. J Neurooncol. In Press.
  • Salans M, Tibbs MD, Karunamuni R, Yip A, Huynh-Le MP, Macari AC, Reyes A, Tringale K, McDonald CR, Hattangadi-Gluth JA. Longitudinal change in fine motor skills after brain radiotherapy and in vivo imaging biomarkers associated with decline. Neuro Oncol. 2021 Aug 2;23(8):1393-1403. doi: 10.1093/neuonc/noab017. PMID: 33543265.
  • Salans M, Tibbs MD, Huynh-Le MP, Yip A, Tringale K, Karunamuni R, Xu R, Reyes A, Macari AC, Pan-Weisz T, McDonald CR, Hattangadi-Gluth JA. Quality of Life Is Independently Associated With Neurocognitive Function in Patients With Brain Tumors: Analysis of a Prospective Clinical Trial. Int J Radiat Oncol Biol Phys. 2021 Nov 1;111(3):754-763. doi: 10.1016/j.ijrobp.2021.05.134. Epub 2021 Jun 6. PMID: 34102297.
  • Yip AT, Yu JD, Huynh-Le MP, Salans M, Unnikrishnan S, Qian AS, Xu R, Kaner R, MacEwan I, Crawford JR, Hattangadi-Gluth JA. Post-treatment neuroendocrine outcomes among pediatric brain tumor patients: Is there a difference between proton and photon therapy? Clin Transl Radiat Oncol. 2022 Feb 25;34:37-41. doi: 10.1016/j.ctro.2022.02.010. PMID: 35345865.
  • Salans M, Tibbs MD, Huynh-Le MP, Hattangadi-Gluth JA. In Reply to Bunevicius et al. Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):612. doi: 10.1016/j.ijrobp.2020.12.058. PMID: 33989581.
  • Huynh-Le MP, Tibbs MD, Karunamuni R, Salans M, Tringale KR, Yip A, Connor M, Simon AB, Vitzthum LK, Reyes A, Macari AC, Moiseenko V, McDonald CR, Hattangadi-Gluth JA. Microstructural Injury to Corpus Callosum and Intrahemispheric White Matter Tracts Correlate With Attention and Processing Speed Decline After Brain Radiation. Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):337-347. doi: 10.1016/j.ijrobp.2020.12.046. Epub 2021 Jan 4. PMID: 33412257.
  • Tibbs MD, Huynh-Le MP, Karunamuni R, Reyes A, Macari AC, Tringale KR, Salans M, Yip A, Liu E, Simon A, McDonald CR, Hattangadi-Gluth JA. Microstructural Injury to Left-Sided Perisylvian White Matter Predicts Language Decline After Brain Radiation Therapy. Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1218-1228. doi: 10.1016/j.ijrobp.2020.07.032. Epub 2020 Jul 23. PMID: 32712255.
  • Salans M, Yip A, Burkeen J, Liu KX, Lee E, Pan-Weisz T, Marshall D, McDuff SGR, Sharifzadeh Y, Dalia Y, Sanghvi P, Simpson D, Xu R, McDonald C, Hattangadi-Gluth JA. Prospective Longitudinal Assessment of Health-related Quality of Life in Patients With Brain Metastases Undergoing Radiation Therapy. Am J Clin Oncol. 2021 Oct 1;44(10):536-543. doi: 10.1097/COC.0000000000000848. PMID: 34392256.
  • Salans, M, Houri, J, Karunamuni, R, Hopper, A, Delfanti, R, Seibert, TM, Bahrami, N, Sharifzadeh, Y, McDonald, C, Moiseenko, V, Farid, N, Hattangadi-Gluth, J. The relationship between radiation dose and bevacizumab-related imaging abnormality (BRIA) in brain tumor patients: a voxel-wise NTCP analysis. PLoS One. Under review.
  • Salans M, Courtney PT, Yip A, Murphy JD. Cost-effectiveness of ipilimumab versus high-dose interferon as an adjuvant therapy in resected high-risk melanoma. Cancer Med. 2021 Oct;10(19):6618-6626. doi: 10.1002/cam4.4194. Epub 2021 Aug 17. PMID: 34402192.
  • Salans M, Riviere P, Vitzthum LK, Nalawade V, Murphy JD. Temporal Trends and Predictors of Opioid Use Among Older Patients With Cancer. Am J Clin Oncol. 2022 Feb 1;45(2):74-80. doi: 10.1097/COC.0000000000000888. PMID: 35019879.
  • Courtney PT, Deka R, Kotha NV, Cherry DR, Salans MA, Nelson TJ, Kumar A, Luterstein E, Yip AT, Nalawade V, Parsons JK, Kader AK, Stewart TF, Rose BS. Active surveillance for intermediate-risk prostate cancer in African American and non-Hispanic White men. Cancer. 2021 Dec 1;127(23):4403-4412. doi: 10.1002/cncr.33824. Epub 2021 Aug 4. PMID: 34347291.
  • Courtney PT, Yip AT, Cherry DR, Salans MA, Kumar A, Murphy JD. Cost-effectiveness of Nivolumab-Ipilimumab Combination Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer. JAMA Netw Open. 2021 May 3;4(5):e218787. doi: 10.1001/jamanetworkopen.2021.8787. Erratum in: JAMA Netw Open. 2021 Jun 1;4(6):e2118586. PMID: 33938936.
  • Sarkar RR, Hatamipour A, Panjwani N, Courtney PT, Cherry DR, Salans MA, Yip AT, Rose BS, Simpson DR, Banegas MP, Murphy JD. Impact of Radiation on Cardiovascular Outcomes in Older Resectable Esophageal Cancer Patients With Medicare. Am J Clin Oncol. 2021 Jun 1;44(6):275-282. doi: 10.1097/COC.0000000000000815. PMID: 33782335.
  • Tringale KR, Huynh-Le MP, Salans M, Marshall DC, Shi Y, Hattangadi-Gluth JA. The role of cancer in marijuana and prescription opioid use in the United States: A population-based analysis from 2005 to 2014. Cancer. 2019 Jul 1;125(13):2242-2251. doi: 10.1002/cncr.32059. Epub 2019 Apr 22. PMID: 31006849.

Redefining Possible